Etoposide bulk supplier for pharma manufacturers

Etoposide Suppliers & Bulk Manufacturers

Available Forms: Oral Capsules & Injection:

Available Strengths: Injection: 20 mg/mL; Capsule: 50 mg

Reference Brands: US: Toposar® (injection) VePesid® (capsules); EU: Etopophos® (injectable phosphate form) Vepesid® (capsules)

Category: Oncology Cancer Care

Etoposide is a chemotherapy drug used for lung, testicular, and blood cancers. Available in 20 mg/mL injection and 50 mg capsules in the US and EU.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Etoposide is a potent oncology agent available in the US and EU, widely used to treat small cell lung cancer, testicular cancer, and various hematologic malignancies. Available as 20 mg/mL injection and 50 mg oral capsules, Etoposide disrupts DNA replication by inhibiting topoisomerase II, leading to cancer cell death. Sold under brand names like Toposar®, VePesid®, and Etopophos®, and as numerous generics, it remains a cornerstone in combination chemotherapy protocols. Etoposide is a trusted and essential option in hospital procurement and pharmaceutical B2B supply chains across regulated markets.

Etoposide — third party manufacturing & bulk supply

Etoposide is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Etoposide is supplied as Oral Capsules & Injection: — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Etoposide listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Etoposide →

Back to Listing

Frequently Asked Questions

Etoposide is listed as Oral Capsules & Injection: in Injection: 20 mg/mL; Capsule: 50 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Etoposide is referenced against US: Toposar® (injection) VePesid® (capsules); EU: Etopophos® (injectable phosphate form) Vepesid® (capsules). Reference brands are shown for identification only and remain the property of their respective trademark owners.